Current Medicinal Chemistry

Nanochemistry-Based Immunotherapy for HIV-1
pp. 1911-1919(9)
Authors: F. Lori,; S.A. Calarota,; J. Lisziewicz,

New Insights on the Perturbations of T Cell Cycle During HIV Infection
pp. 1920-1924(5)
Authors: Domenico Galati,; Marialuisa Bocchino,

Eosinophilopoiesis at the Cross-Roads of Research on Development, Immunity and Drug Discovery
pp. 1925-1939(15)
Authors: P. Xavier Elsas,; M.I. Gaspar Elsas,

Cross-Talk Between NO and Arachidonic Acid in Inflammation
pp. 1940-1944(5)
Authors: Sofia Mariotto,; Ylenia Suzuki,; Tiziana Persichini,; Marco Colasanti,; Hisanori Suzuki,; Orazio Cantoni,

The Involvement of the Nitric Oxide in the Effects and Expression of Opioid Receptors During Peripheral Inflammation
pp. 1945-1955(11)
Author: Olga Pol,

Biological Markers for Multiple Sclerosis
pp. 1956-1965(10)
Authors: Andreas Lutterotti,; Thomas Berger,; Markus Reindl,

Antileukotriene Drugs: Clinical Application, Effectiveness and Safety
pp. 1966-1977(12)
Authors: G. Riccioni,; T. Bucciarelli,; B. Mancini,; C. Di Ilio,; N. D'Orazio,

Monoclonal Antibody “Gold Rush”
pp. 1978-1987(10)
Author: Krishan Maggon,

Hepatobiliary Diseases and Insulin Resistance
pp. 1988-1999(12)
Authors: Nahum Mendez-Sanchez,; Noberto C. Chavez-Tapia,; D. Zamora-Valdes,; Roberto Medina-Santillan,; Misael Uribe,

Novel Agents in the Management of Mycobacterium Tuberculosis Disease
pp. 2000-2008(9)
Authors: P.J. Barry,; T.M. O'Connor,